Abiraterone acetate is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. It is an ester prodrug of Abiraterone, an anticancer agent. This compound targets Cytochrome P450 and is used in cancer research, particularly for its role in prostate cancer.
- Targeted inhibition of cytochrome P450
- Oral, potent, selective, and irreversible inhibitor of CYP17A1
- Exhibits antiandrogen activity
- Functions as a prodrug of Abiraterone
- Inhibits proliferation of AR-positive prostate cancer cell lines
- Prolongs survival in castration-resistant prostate cancer (CRPC)
- For research use only